Quantcast
Last updated on April 16, 2014 at 17:34 EDT

Latest Sinovac Biotech Stories

2010-10-17 20:10:00

SHANGHAI, Oct. 17 /PRNewswire-Asia/ -- At the end of 2009, the vaccine industry raised so much concern worldwide that the headlines of the business media were occupied by various kinds of news about vaccine enterprises. For example, Sinovac Biotech Co., Ltd. successfully landed on the Nasdaq, then Simcere, a pharmaceutical company based in Jiangsu Province, listed on the NYSE, announced a 50.8% stake in Ealong Biotech and took control of the latter, and finally Novartis, the world-famous...

2010-09-07 07:00:00

BEIJING, Sept. 7 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that Mr. Weidong YIN, Chairman, President & CEO, Mr. Jacob Chik Keung HO, Acting CFO and Ms. Xiaohong WU, Senior Financial Manager, are scheduled to participate in three upcoming investor conferences to be held in September 2010. -- Morgan Stanley Global Healthcare Unplugged Conference, New York, NY, September 13-14: Sinovac's presentation...

2010-08-16 05:30:00

BEIJING, Aug. 16 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 30, 2010. Financial Highlights -- Second quarter sales increased 131% to $10.3 million on a sequential quarter basis and decreased by 49% year-over-year -- Sales for the six-month period declined 45% to $14.7 million, compared to same period last...

2010-08-05 07:00:00

BEIJING, Aug. 5 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it will release its financial results for the second quarter ended June 30, 2010 before the open of the market on Monday, August 16, 2010. The Company will host a conference call on Monday, August 16, 2010 at 8:00 a.m. ET to review the Company's financial results and provide an update on recent corporate developments. To access the...

2010-07-15 07:00:00

BEIJING, July 15 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it held its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted in person or by proxy. The meeting was held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua....

2010-06-25 08:00:00

SHANGHAI, June 25 /PRNewswire-Asia/ -- "Life or death for a young child too often depends on whether he is born in a country where the vaccines are available or not." -- Nelson Mandela Hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2010 on Sept 15 and 16 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China...

2010-06-18 07:00:00

BEIJING, June 18 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading developer and provider of vaccines in China, announced today that it will hold its 2010 Annual Meeting of Shareholders on Thursday, July 15, 2010 at 9:00 a.m. Beijing Time. The meeting will be held concurrently at No. 39 Shangdi Xi Road, Haidian District, Beijing, PRC and at No. 6 Temple Street, St. John's, Antigua. All shareholders of record as of May 26, 2010 will be eligible to vote and are invited to...

2010-06-01 07:00:00

BEIJING, June 1 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that it has received the confirmation from the China International Tendering Company that Sinovac was selected by the Beijing Centers for Diseases Control and Prevention (Beijing CDC) to supply the Company's hepatitis A vaccine, Healive, to the Beijing Expanded Program of Immunization (EPI). As part of the bidding process, the Beijing CDC evaluates...

2010-05-26 07:00:00

BEIJING, May 26 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that the Company will participate at the 2010 Shanghai CPhI Exhibition, being held June 2-4, 2010. Sinovac's exhibition booth will be located in Hall E4, No. E4C42. At the exhibition, Sinovac will showcase its commercialized products, including its Healive, Anflu, Panflu and Panflu.1 vaccines. Mr. Weidong Yin, Chairman, President and CEO of Sinovac,...

2010-05-24 07:00:00

BEIJING, May 24 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading China-based vaccine manufacturer, announced today that Mr. Weidong Yin, Chairman, President & CEO, will present at the 2010 UBS Global Specialty Pharmaceuticals Conference, which is being held June 2-3, 2010 in London, England. Sinovac's presentation is scheduled for Wednesday, June 2, 2010 at 10 a.m. BST/5 a.m. Eastern Time. A live webcast of the presentation will be available online on the...